Using SphK2-deficient transgenic mice revealed that SphK2 deficiency had no effect on arthritis severity, whereas the use of a SphK2 inhibitor resulted in increased arthritis severity (38). This evidence concerns the gene SPHK2 and arthritic joint disease.